Related Experiment Video
Updated: Sep 14, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
[Translated article] Role of the pharmacist in antimicrobial stewardship programs in critically ill patients
Miguel Ángel Amor García1, Irene Aquerreta González2, Carla Bastida Fernández3
1Servicio de Farmacia, Hospital Universitario Infanta Cristina, Madrid, Spain.
Abstract:
The design and implementation of antimicrobial stewardship programs for patients admitted to intensive care units must consider the specific characteristics of this population, including infection severity, organ dysfunction, and pharmacokinetic/pharmacodynamic alterations. The creation of a multidisciplinary team and the establishment of clear, targeted objectives are essential to improve treatment appropriateness, reduce the emergence of antimicrobial resistance, and ensure the sustainability of healthcare system. Pharmaceutical care contributes to the optimisation of antimicrobial use through antimicrobial therapy review, dose individualisation based on pharmacokinetic/pharmacodynamic parameters, and treatment monitoring, while also facilitating the development of systems for monitoring clinical outcomes, microbiology, and antimicrobial consumption.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Microbiota Modulation by Antibiotics
Mechanism of Antibiotic Resistance in MRSA
Acute Pyelonephritis II: Diagnostic Studies and Management
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
